Kestra Medical Technologies

NCT03887052

ASSURE WCD Clinical Evaluation - Detection and Safety Study

NCT04132466

ASSURE WCD Clinical Evaluation - Conversion Efficacy Study

NCT05135403

ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)

NCT06154408

Evaluating the Impact of Omega-3 Fatty Acid Supplementation (Soloways™) on Lipid Profiles in Adults With PPARG Polymorphisms

NCT06163443

Evaluating the Impact of B Vitamin Supplementation (Soloways™) on Homocysteine and LDL-C Levels in Patients With MTHFR, MTR, and MTRR Polymorphisms.

NCT06188832

Efficacy of Dietary Fiber Supplementation (Soloways) in Patients With Specific Genetic Polymorphisms

NCT06470412

Personalized Management of Autoimmune Diseases With AI-Guided (GenAIS TM) Dietary Supplementation

NCT06215196

Effectiveness and Safety of Semaglutide Combined With Dietary Fiber (Soloways) in Adults With Overweight or Obesity

NCT06221696

Preventing Weight Regain Post-Semaglutide Treatment With Active Fiber Supplement (Soloways)

NCT06313164

The Impact of Oral Glutathione on Oxidative Damage and Glycated Hemoglobin (HbA1c) Levels in Type 2 Diabetes Patients

NCT06328348

Assessing the Synergistic Effects of Black Cohosh, Soy Isoflavones, and SDG Lignans (Soloways TM) on Menopausal Symptoms

NCT06264570

Evaluation of a Genetically Determined Personalized Approach in Prescribing Biologically Active Substances in Patients With Elevated Blood Homocysteine Levels.

NCT06448234

Evaluating the Efficacy of AI-Guided (GenAIS TM) vs. Standard Physician-Guided Dietary Supplement Prescriptions for Lowering LDL Cholesterol in Hypercholesterolemic Patients

NCT06458296

Evaluating the Efficacy of AI-Guided (GenAIS TM) vs. Standard Physician-Guided Dietary Supplement Prescriptions for Weight Loss in Obese Patients

NCT06469658

Personalized Management of Type 2 Diabetes Using AI-Guided (GenAIS TM) Dietary Supplementation

NCT06470425

Optimizing Mental Health Management With AI-Guided (GenAIS TM) Dietary Supplementation

NCT06357936

Nanofat Grafting as a Method of Treating Critical Limb Ischemia

NCT06264544

Trial to Evaluate the Efficacy of a Zinc, Selenium, and L-Tyrosine Supplement in the Prevention of Thyrotoxicosis in Subjects With r25191G/A SEPP1 Polymorphism